Literature DB >> 16197480

Flowcytometric analysis of basophil counts in human blood and inaccuracy of hematology analyzers.

S Ducrest1, F Meier, C Tschopp, R Pavlovic, C A Dahinden.   

Abstract

BACKGROUND: Differential leukocyte counts are of proven clinical value, but information about basophil counts in normal and disease conditions is scarce although basophils are regarded as key effector cells in allergy. AIMS: To establish and validate flowcytometric methods for counting basophils in peripheral human blood, to determine reference values, and to examine the accuracy of two widely used hematology analyzers.
METHODS: Basophils were measured in whole blood by flowcytometry after staining with antibodies against the IL-3-receptor (CD123) or the eotaxin-receptor (CCR3) combined with other markers used for gating or validation purposes.
RESULTS: The basophil percentages in 95 healthy adults showed an excellent correlation between the two independent flowcytometric methods, demonstrating that both are accurate and precise. The most robust maker is CCR3, which seems to be sufficient to specifically identify basophils. Normal values of relative and absolute blood basophils counts were 0.22-1.28% and 0.014-0.087 G/L (95% reference intervals), respectively. Basophil counts measured with two hematology analyzers Coulter GEN-S and ADVIA-120 showed no correlation between these instruments. Comparing the data obtained by flowcytometry and the analyzers demonstrate that basophil counts of the GEN-S are erratic, while the ADVIA-120 gives at least an estimation of true basophil numbers.
CONCLUSIONS: We provide a solid description and validation of a novel and rapid method for the flowcytometric enumeration of basophil in whole blood. The fact that the most heavily used Hematology autoanalyzer gives completely erroneous results could explain why basophils counts have not yet received recognition as a clinically useful diagnostic marker.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16197480     DOI: 10.1111/j.1398-9995.2005.00910.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  6 in total

1.  Clinical safety of Food Allergy Herbal Formula-2 (FAHF-2) and inhibitory effect on basophils from patients with food allergy: Extended phase I study.

Authors:  Sangita P Patil; Julie Wang; Ying Song; Sally Noone; Nan Yang; Sylvan Wallenstein; Hugh A Sampson; Xiu-Min Li
Journal:  J Allergy Clin Immunol       Date:  2011-07-26       Impact factor: 10.793

2.  Basophil sensitivity through CD63 or CD203c is a functional measure for specific immunotherapy.

Authors:  Susan Mikkelsen; Bo Martin Bibby; Mette Konow Bøgebjerg Dolberg; Ronald Dahl; Hans Jürgen Hoffmann
Journal:  Clin Mol Allergy       Date:  2010-02-16

3.  Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform.

Authors:  Peter Valent; Thomas Lion; Dominik Wolf; Christian Sillaber; Hermine Agis; Andreas Petzer; Alois Lang; Peter Kalhs; Dietmar Geissler; Richard Greil; Werner Linkesch; Sonja Burgstaller; Josef Thaler; Günther Gastl
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 4.  Basophil Activation Test: Old and New Applications in Allergy.

Authors:  Oliver Hemmings; Matthew Kwok; Richard McKendry; Alexandra F Santos
Journal:  Curr Allergy Asthma Rep       Date:  2018-11-15       Impact factor: 4.806

5.  Differential response of human basophil activation markers: a multi-parameter flow cytometry approach.

Authors:  Salvatore Chirumbolo; Antonio Vella; Riccardo Ortolani; Marzia De Gironcoli; Pietro Solero; Giuseppe Tridente; Paolo Bellavite
Journal:  Clin Mol Allergy       Date:  2008-10-16

6.  Basophil markers for identification and activation in the indirect basophil activation test by flow cytometry for diagnosis of autoimmune urticaria.

Authors:  Zehwan Kim; Bong Seok Choi; Jong Kun Kim; Dong Il Won
Journal:  Ann Lab Med       Date:  2016-01       Impact factor: 3.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.